TELEMANAGEMENT OF INFLAMMATORY BOWEL DISEASE

Table of contents (11 chapters)
1.Barriers to Successful Outcomes in Patients with Inflammatory Bowel Diseases
2.Experience with Telemedicine Systems in Chronic Illness: What Can We Learn
3.Telephone Encounters in Inflammatory Bowel Disease (IBD) Care: Burden, Risk Factors, and Opportunities for Intervention
4.Teleconsultation in the Care of Patients with IBD
5.Self-Management Techniques in IBD
6.Mobile Applications for Patients with Inflammatory Bowel Disease
7.Telemonitoring and Self-Care in Patients with IBD
8.Teleconferences to Facilitate Multidisciplinary Care and Education in IBD
9.System Requirements for Delivery of Telemedicine Services
10.Legal, Regulatory, and Ethical Issues in the Use of Telemedicine
11.Future Directions in Telemedicine Applications for Inflammatory Bowel Disease (IBD)

- Unique and state-of-the-art review of IBD and its management through telemedicine applications
- Features a summary of the impact of telemedicine in other chronic illnesses
- Written by experts in their fields
This volume provides a comprehensive, state-of-the art review of inflammatory bowel disease and its management through the use of telemedicine applications. The book reviews barriers to successful outcomes in patients with IBD and offers a rationale for how self-management and telemedicine approaches can improve care in chronic illnesses such as IBD. This volume also includes a summary of the burden of telephone encounters in patients with IBD, characteristics of frequent callers to the office, outcomes associated with high telephone use, and strategies to provide education via telephone to patients with IBD. Prior literature on implementation of teleconsultation in research and clinical practice, as well as mobile applications used to track symptoms, quality of life, diet, and medication use in IBD are also explored in the book.
Written by experts in the field, Telemanagement of Inflammatory Bowel Disease is a valuable resource for gastroenterologists, surgeons, and other clinicians dealing with, and interested in, this novel adjunct to routine care for inflammatory bowel disease.

Authors
- Raymond K. Cross, MD, MS, AGAF. Associate Professor of Medicine, Director of the IBD Program, University of Maryland, Baltimore, Department of Medicine, Division of Gastroenterology and Hepatology, Baltimore, MD, USA
- Andrew R. Watson, MD, MLitt., FACS. Vice-President, International Division, University of Pittsburgh Medical Center, Department of Colorectal Surgery, Pittsburgh, PA, USA